{"podcast":{"title":"Los Angeles News Today | 2 Min News | The Daily News Now!","slug":"los-angeles-news-today-2-min-news-the-daily-news-now-7458113","podcast_index_feed_id":7458113,"rss_url":"https://feeds.fastcast.ai/the-los-angeles-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/dce2f6a7-6295-42f0-9d04-21dbdce5a096.jpeg","author":"The Daily News Now!","episode_count":1626,"summary":"Hosted by Corey with the Story, Los Angeles News Today delivers fast, focused daily updates on the stories shaping Los Angeles—from local news and business to entertainment, sports, and culture. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes in one of the world’s most influential cities. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—bringing local news to every city in the world and keeping communities connected. Los Angeles News Today is your daily snapshot of what’s happening across LA. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-24T22:19:31.018392+00:00","page_url":"https://stenobird.com/podcast/los-angeles-news-today-2-min-news-the-daily-news-now-7458113"},"episode":{"title":"FDA Approves First Alzheimer’s Drug in Decades","slug":"fda-approves-first-alzheimer-s-drug-in-decades","published_at":"2026-05-26T04:53:32+00:00","page_url":"https://stenobird.com/podcast/los-angeles-news-today-2-min-news-the-daily-news-now-7458113/fda-approves-first-alzheimer-s-drug-in-decades","show_page_url":"https://stenobird.com/podcast/los-angeles-news-today-2-min-news-the-daily-news-now-7458113","url":"https://api.fastcast.ai/audio/0b87382b-b4e0-4238-80b9-46d51c86d995.mp3","audio_url":"https://api.fastcast.ai/audio/0b87382b-b4e0-4238-80b9-46d51c86d995.mp3","summary":"FDA just approved Lecanemab, the first drug in years to target amyloid plaques in early Alzheimer’s — offering hope but with caution. It slows cognitive decline modestly in clinical trials, yet isn’t a cure and carries risks like brain swelling and bleeding. Doctors will need to closely monitor patients as real-world data rolls in. This breakthrough signals a new chapter in Alzheimer’s treatment — and a reminder that science must keep pushing forward. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/f74a99980bd6b6f4","meta_description":"FDA just approved Lecanemab, the first drug in years to target amyloid plaques in early Alzheimer’s — offering hope but with caution. It slows cognitive d…","key_points":[],"chapters":[],"topics":[],"duration_seconds":102,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/los-angeles-news-today-2-min-news-the-daily-news-now-7458113/episodes/fda-approves-first-alzheimer-s-drug-in-decades/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/los-angeles-news-today-2-min-news-the-daily-news-now-7458113/fda-approves-first-alzheimer-s-drug-in-decades.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}